Home

About Us

Pharma-Free CME

Resources by Topic

Resources by Type

Teaching Tools

Drug Industry

Contact Us

RSS NEWS FEED

Home

PharmedOut is an independent, publicly funded project that empowers physicians to identify and counter inappropriate pharmaceutical promotion practices. PharmedOut promotes evidence-based medicine by providing news, resources, and links to pharma-free CME courses.

Pharma-Free CME

More than 200 free web-based CME credits are available without cost.

Resources by Topic

Drug promotion, drug information, evidence-based
medicine, docs and pharma, industry-sponsored research, conflict of interest, direct-to-consumer advertising, drug reps, and other topics.

Resources by Type

Articles, reports, slide shows, databases, subscribables, and links to other organizations and websites.

Teaching Tools

No Drug Reps Certificate, Drug Ad Bingo, and other materials for educators.

---

PharmedOut Publications

PharmedOut in the Media

News Archive

How You Can Help

Our Videos



Pharma Insider II
Opposition research
(read transcript)

---

Pharma Insider I
Off-label promotion under the radar
(read transcript)

---

The Art of Medical Writing
Pharma's anonymous writers

---

Drug Reps Talk Shop II
Drug reps continue their chat

---

Drug Reps Talk Shop I Selling drugs to docs

---

Director of PharmedOut Explains the Project

---

Zyprexa Drug Rep Tells All Shahram Ahari describes how he sold the drug

---

News

Drug Maker Said to Pay Ghostwriters for Journal Articles
PremPro paper trail NYT (read public documents)

---

New Study Firmly Ties Hormone Use to Breast Cancer
WHI analysis finds risk doubled WP

---

Conflicts of Interest in Continuing Medical Education
CME at East Carolina U almost pharma-free Inside Higher Ed

---

Outsourced to India: Clinical Drug Trials
Nearly half of clinical studies off-shored St. Petersburg Times

---

FDA Adds Suicide Warning to Epilepsy Drugs
Lamictal, Topamax and Lyrica AP

---

Drug Company Sued Over Heart Treatment for Preemies
FTC charges Ovation with price-gouging Chicago Tribune

---

Consumer Medication Information Not Consistently Useful
50% of private-sector info minimally useful FDANews (read report)

---

Spinal Tap: Medtronic and a Patient Death
Devicemaker unaware of Infuse BoneGraft-related death Pharmalot

---

FDA’s $1.5 Million Morale Contract
Boosting job satisfaction? Bloomberg

---

Johnson & Johnson, Texas and Medicaid Fraud
Kickbacks to officials Pharmalot

---

Commentary

Nobel Laureate Calls for Public Funding of Drug Trials
Head-to-head comparisons urged WSJ Health Blog (read article in Health Affairs)

---

Absence of Evidence
Positive studies more likely to be published Economist

---

Click HERE to read the entire news archives